Ng and Smith are going to touch on topics such as understanding which drug products are eligible for regulatory exclusivity, the different modes and methods of non-patent regulatory exclusivity, and using trade dress as a means of exclusivity.George Ng is a partner in the firm???s Business and Finance practice group.